Skip to content

Pathodx Positive Control

by Remel Europe Ltd

Ref R24042

Pathodx Positive Control (R24042) is an in vitro diagnostic device (EU IVDR Class C; FDA Class I; FDA product code GTZ, Antisera, All Groups, Streptococcus Spp.; EMDN category streptococcal reagents) made by Remel Europe Ltd, registered in EUDAMED on 6 Apr 2026 (Basic UDI-DI 50560805PathoDXReagPCQV), cleared under FDA 510(k) K871831 on 17 Jun 1987 and listed in FDA GUDID since 21 Jul 2021 (UDI-DI 05056080501291), active as of 22 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K871831

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number50560805PathoDXReagPCQV Basic UDI-DI 05056080501291UDI-DIDate6 Apr 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05056080501291 UDI-DI Date21 Jul 2021ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK871831 Date17 Jun 1987DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 50560805PathoDXReagPCQV registered 6 Apr 2026 Active
  • FDA 510(k) K871831 decided 17 Jun 1987 Active
  • FDA GUDID UDI-DI 05056080501291 listed 21 Jul 2021 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K871831
  2. Listed FDA GUDID 05056080501291
  3. Registered EUDAMED 50560805PathoDXReagPCQV

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Generic name
Beta-haemolytic Streptococcus serological grouping IVD, control
Model / reference
R24042 EUDAMED
R62042 GUDID
Primary DI / UDI-DI
05056080501291
Basic UDI-DI
50560805PathoDXReagPCQV
510(k) Number
FDA product code
GTZ
EMDN code
W0105011199 Streptococcal reagents - other
GMDN term
Beta-haemolytic Streptococcus serological grouping IVD, control
Device class
Class C EUDAMED
Class I GUDID
Regulation number
866.3740
EU registration type
Standard device
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
R24042
GUDID
R62042
Device classEUDAMED
Class C
GUDID
Class I

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
GB-MF-000016733
Authorised representative
Thermo Fisher Diagnostics B.V. NL-AR-000013157

Similar devices in this category

Other devices filed under STREPTOCOCCAL REAGENTS - OTHER.

Other devices from Remel Europe Ltd

See all devices from Remel Europe Ltd →

Properties

  • Contains substances of microbial origin
  • Reagent
  • Professional testing
  • Lot / batch number
  • Expiration date
Other properties (21, all answered No)